AbbVie said its atopic dermatitis treatment Rinvoq (ingredient: upadacitinib) has proved its superiority over dupilumab in the phase 3b study on their safety and efficacy.Both were used as mono-therapy treatments on moderate to severe atopic dermatitis adult patients.The research paper was based on
The U.S. Health and Human Services (HHS) Office of Inspector General said Wednesday that it would investigate the U.S. Food and Drug Administration’s process in approving Aduhelm (ingredient: aducanumab), Biogen’s Alzheimer’s disease treatment.The FDA recently approved Aduhelm with an accelerated ap
Vigencell, a company specializing in immune cell treatments’ research and development, said it plans to go public in the Kosdaq stock market next week. Ahead of its IPO, the company presented its major pipelines, competitiveness, visions, and strategies in a news conference on Thursday.Vigencell aim
Maria Trading, the platinum sponsor of MISS Iraq 2021 with the crowned beauty (Maria Frhad) as its official brand ambassador, seeks to grow into a top company that provides medical aesthetics products in the Arabian Gulf region.The company, a leading player in dermatology and aesthetic sectors in th
PharmaResearch said Friday that its polynucleotide (PN)-based medical device, Rejuran HB Plus, has won approval from the Ministry of Food and Drug Safety and plans to begin marketing from the second half of the year.The company has upgraded Rejuran HB Plus by adding hyaluronic acid (HA) and lidocain
Novartis Korea said Monday its interleukin-17a (IL-17a) inhibitor Cosentyx (ingredient: secukinumab) began receiving reimbursement as a first-line biologics for progressive psoriatic arthritis (PsA) patients who had an inadequate response to existing disease-modifying antirheumatic drugs (DMARDs).Wi
ViiV Healthcare, the HIV specialist owned by GlaxoSmithKline plc. (GSK), presented Dovato’s 48-week data of the phase 3 SALSA and 144-week data of TANGO at the 2021 International AIDS Society.The 2021 International AIDS Society was held online from July 18-21. Dovato, HIV treatment, is a two-drug re
GC Pharma has signed a joint research and license agreement to develop orally administered chaperone therapy of gangliosidosis (GM1) with Japans’ Tottori University.A neurodegenerative disease, GM1 is a recessively inherited genetic defect that leads to a lack of enzymes in the body. It happens to o
Korea marked the first trade surplus in pharmaceutical products last year since the nation began compiling related data in 1998, the government said.On Sunday, the Ministry of Food and Drug Safety released the data of Korea’s output, export, and import of medicines in 2020.The data showed that the n
Large domestic pharmaceutical companies are likely to continue their growth pattern as they increased sales in the second quarter despite slight drops from the first three months.Hanmi Pharmaceutical, Daewoong Pharmaceutical, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical began to release th
The fiasco over carcinogen-containing valsartan drugs that broke out three years ago changed the prescription market for valsartan-based antihypertensive single and combination drugs.In July 2018, the Ministry of Food and Safety had prohibited sales of 174 valsartan-based hypertension treatments aft
The outpatient prescription of sodium-glucose cotransporter 2 (SGLT2) inhibitors in the first half of 2021 in Korea increased 12 percent from the same period of last year to reach 64.3 billion won ($55.9 million).According to the outpatient prescription report of UBIST, the gap between AstraZeneca’s
Korea’s Covid-19 diagnostic kit makers are shifting from detecting the virus to confirming the formation of virus-neutralizing antibodies among vaccinated people as the pandemic prolongs, industry insiders said Friday.The biggest reason is the uncertainty of generating the antibodies, as people test
JW Pharmaceutical said Friday that the Ministry of Food and Drug Safety has approved two Livalozet products – 2/10 mg and 4/10 mg -- pitavastatin-based combination drugs for dyslipidemia.The ministry based its approval on phase 3 clinical trial of Livarozet in 25 hospitals, including Gangdong Sacred
Pfizer Korea said that its ALK (anaplastic lymphoma kinase)-positive non-small cell lung cancer (NSCLC) treatment Lorviqua 25mg and 100mg had received approval from the Ministry of Food and Drug Safety.While the ministry approved the drug to treat adult patients with ALK-positive advanced NSCLC, hos
Pharmaceutical companies manufacturing novel oral anticoagulants (NOAC) showed contrasting results in outpatient prescriptions in the first half of 2021, a market surveyor said Thursday.Some domestic NOAC generic makers have been expelled from the market, while original NOAC developers absorbed the
The prescription of chronic disease drugs Celltrion acquired from Takeda Pharmaceuticals decreased in the first half of this year from a year ago.According to UBIST, a drug market research firm, the total prescription amount of drugs Celltrion took over from Takeda Pharmaceutical stood at 33.4 billi
The Ministry of Food and Drug Safety has suspended the manufacturing of six drugs produced by Samyang Holdings for one month due to the violation of drug production management obligations and consignee management responsibilities.The ministry suspended six drugs -- three nicotine patches (Nicostop-1
GC Pharma applied for building and running a Biosafety Level 3 (BL3) research facility to the Korea Disease Control and Prevention Agency (KDCA) on Wednesday.The company said it is the first Korean drugmaker attempting to construct a BL3 facility.The biosafety level is an administrative standard use
Daewoong Pharmaceutical said Wednesday that the company and Hanall Biopharma would expand their “open collaboration” by jointly investing in the U.S. biopharmaceutical industry.Daewoong and Hanall have invested in NurrOn Pharmaceuticals' Series A round for developing novel therapies for Parkinson's